TORONTO, May 28, 2026, 12:01 EDT
Zentek Ltd. shares traded just above flat in Toronto late Thursday morning, still below the price of a new C$18 million financing that the graphene and graphite developer closed a day earlier. The stock was at about C$0.80 on the TSX Venture Exchange, up 0.63%, while the company sold units in the financing at C$1.00 each.
That gap is the point for investors now. Zentek has fresh cash to push its Albany Graphite project and ZenGUARD air-filter business, but the market is still pricing the stock as a small-cap story with dilution, commercialization risk and a Nasdaq listing issue to clear.
The company said on Wednesday it sold 18 million units, including the full exercise of an agent’s option, in a brokered private placement led by Red Cloud Securities. Each unit included one common share and one warrant, which gives the holder the right to buy another share at C$1.50 until May 27, 2029.
“Closing this financing reflects confidence in the value-creation path,” Chief Executive Mohammed Jiwan said in the company’s release. He said Zentek was now “well-capitalized to advance our near-term priorities.” TMX Newsfile
The money is earmarked for development and “derisking” of Albany Graphite, including a new Preliminary Economic Assessment, or PEA — an early study of whether a mineral project may make economic sense. Zentek also plans to use proceeds for ZenGUARD commercialization, payments due, working capital and corporate needs. TMX Newsfile
The U.S. listing told a weaker story. Zentek’s Nasdaq shares were recently at $0.5709, down from their previous close, with light volume, according to market data.
That matters because Zentek remains below Nasdaq’s $1.00 minimum bid rule. The company said in February it had received a 180-day extension and must maintain a closing bid of at least $1.00 for at least 10 straight business days by Aug. 24, 2026, to regain compliance.
The financing follows a run of May announcements. Zentek said earlier this month that Canada’s Innovative Solutions Canada program added ZenGUARD Enhanced Air Filters to its Pathway to Commercialization source list, allowing federal departments and agencies to buy them directly for three years. The company also said National Research Council testing showed the filters lifted viral filtration efficiency of a standard MERV 8 filter about fivefold in a single air exchange, with no measurable hit to airflow or energy use.
That is still not the same as orders. The same disclosure said inclusion on the government source list does not guarantee minimum contracts, leaving the pace of ZenGUARD revenue as a live question.
Zentek is also trying to stand out in a crowded graphite and advanced-materials field. Nouveau Monde Graphite, a larger Canadian peer in graphite-based materials, recently drew Eni into a US$297 million capital increase tied to its Matawinie mine and Bécancour battery-materials plant, while NanoXplore, a graphene peer, reported C$32.3 million in Q3-2026 revenue this month.
The risk is that the new money buys time, not proof. If Albany’s PEA slips, ZenGUARD orders build more slowly than expected, or Nasdaq compliance remains unresolved, investors may focus more on the 18 million new shares and warrants than on the balance-sheet relief.
For now, the stock is trading like a show-me name. Zentek has closed the raise; the next move has to come from execution.
